MONOCYTES SUBPOPULATIONS AND CHEMILUMINESCENT ACTIVITY IN PATIENTS WITH RENAL CELL CARCINOMA
https://doi.org/10.15789/1563-0625-2015-2-141-150
Abstract
The aim of present study was to investigate the relationship between phenotypic features of monocytes and intensity of “respiratory burst” in the patients with renal cell carcinoma (RCC). A total of 73 patients with RCC (Т3N0М0, clear cell type) participated in the study. Phenotyping of blood monocytes was performed by flow cytometry. The level of “respiratory burst” in monocytes was determined using spontaneous and zymosan-induced luminol- and lucigenin-dependent chemiluminescence. Suffficient changes in phenotypic structure and intensity of “respiratory burst” were identified in peripheral blood monocytes of the patients. Alterations of monocytic subpopulations in RCC were characterized by increased numbers of cells with the CD14lowCD16+ (“non-classical”) phenotype. The imbalance in expression of activation markers was found among monocyte populations from cancer patients; we have revealed a reduced number of monocytes expressing HLA-DR-antigen, and increased number of CD64-positive cells. Meanwhile, intensity of “respiratory burst” in the total monocyte population proved to be reduced in RCC patients. In this case, the characteristic features of the “respiratory burst” intensity distribution among monocytes were as follows: in RCC, a reduced “respiratory burst” activity was found in monocytes with CD14+CD16- phenotype, being, however, increased in the monocytes with CD14+CD16+ and CD14lowCD16+ phenotypes. Such redistribution may be due to increasing role of the given monocyte subsets in immunopathogenesis of renal cell carcinoma.
About the Authors
A. A. Savchenko
Research Institute for Medical Problems of the North, Krasnoyarsk, Russian Federation
Russian Federation
Russian Federation
PhD, MD (Medicine), Professor, Head of Laboratory, Research Institute for Medical Problems of the North, Krasnoyarsk, Russian Federation
A. G. Borisov
Research Institute for Medical Problems of the North, Krasnoyarsk, Russian Federation
Russian Federation
Russian Federation
PhD (Medicine), Leading Research Associate, Research Institute for Medical Problems of the North, Krasnoyarsk, Russian Federation
A. A. Modestov
Krasnoyarsk A.I. Kryzhanovsky Regional Clinical Oncology Center, Krasnoyarsk, Russian Federation
Russian Federation
Russian Federation
PhD (Medicine), Chief Physician, Krasnoyarsk A.I. Kryzhanovsky Regional Clinical Oncology Center, Krasnoyarsk, Russian Federation
A. V. Moshev
Research Institute for Medical Problems of the North, Krasnoyarsk, Russian Federation
Russian Federation
Russian Federation
Postgraduate Student, Research Institute for Medical Problems of the North, Krasnoyarsk, Russian Federation
I. V. Kudryavtsev
Research Institute of Experimental Medicine 197376, Russian Federation, St. Petersburg, Acad. I.P. Pavlov str., 12.
Far Eastern Federal University, Vladivostok, Russian Federation
Russian Federation
Russian Federation
PhD (Biologie), Senior Research Associate, Research Institute of Experimental Medicine, St. Petersburg; Far Eastern Federal University, Vladivostok, Russian Federation
O. G. Tonacheva
Krasnoyarsk A.I. Kryzhanovsky Regional Clinical Oncology Center, Krasnoyarsk, Russian Federation
Russian Federation
Russian Federation
Head of Department, Oncologist, Krasnoyarsk A.I. Kryzhanovsky Regional Clinical Oncology Center, Krasnoyarsk, Russian Federation
V. N. Koshcheev
Research Institute for Medical Problems of the North, Krasnoyarsk, Russian Federation
Russian Federation
Russian Federation
Postgraduate Student Research Institute for Medical Problems of the North, Krasnoyarsk, Russian Federation
References
1. Аполихин О.И., Сивков А.В., Солнцева Т.В., Комарова В.А. Анализ урологической заболеваемости в Российской Федерации в 2005-2010 годах // Экспериментальная и клиническая урология, 2012. No 2. С. 4-12. [Apolihin O.I., Sivkov A.V., Solnceva T.V., Komarova V.A. Analysis of urologic diseases in the Russian Federation in 2005-2010. Eksperimental`naya i klinicheskaya urologiya = Experimental and Clinical Urology, 2012, no. 2, pp. 4-12. (In Russ.)]
2. Головкин А.С., Матвеева В.Г., Кудрявцев И.В., Григорьев Е.В., Великанова Е.А., Байракова Ю.В. Субпопуляции моноцитов крови при неосложненном течении периоперационного периода коронарного шунтирования // Медицинская иммунология, 2012, Т. 14, No 4-5. С. 305-312. [Golovkin A.S., Matveeva V.G., Kudrjavcev I.V., Grigor’ev E.V., Velikanova E.A., Bajrakova Ju.V. Blood monocyte subpopulations during uncomplicated coronary artery bypass surgery. Meditsinskaya immunologiya = Medical Immunology (Russia), 2012, Vol. 14, no. 4-5, pp. 305-312. (In Russ.)]
3. Владимиров Ю.А., Проскурина Е.В. Свободные радикалы и клеточная хемилюминесценция // Успехи биологической химии, 2009. T. 49. C. 341-388. [Vladimirov Ju.A., Proskurina E.V. Free radicals and cellular chemiluminescence. Uspekhi biologicheskoy khimii = Advances of Biological Chemistry, 2009, Vol. 49, pp. 341-388. (In Russ.)]
4. Зурочка А.В., Котляров А.Н., Кувайцев М.В., Квятковская С.В., Зурочка В.А., Рябова Л.В., Хайдуков С.В. Изменение экспрессии HLA-DR-антигенов на моноцитах у детей и ее клиническая значимость при сепсисе // Медицинская иммунология, 2008. Т. 10, No 4-5. С. 379-388. [Zurochka A.V., Kotljarov A.N., Kuvajcev M.V., Kvjatkovskaja S.V., Zurochka V.A., Rjabova L.V., Khajdukov S.V. Changes of HLA-DR antigen expression on monocytes in children and their clinical significance in sepsis. Meditsinskaya immunologiya = Medical Immunology (Russia), 2008, Vol. 10, no. 4-5, pp. 379-388. (In Russ.)]
5. Куртасова Л.М., Савченко А.А., Шкапова Е.А. Клинические аспекты функциональных нарушений нейтрофильных гранулоцитов при онкопатологии. Новосибирск: Наука, 2009. 184 с. [Kurtasova L.M., Savchenko A.A., Shkapova E.A. Clinical aspects of functional disorders of neutrophil granulocytes in oncopathology]. Novosibirsk: Nauka, 2009. 184 p.
6. Писарева Л.Ф., Бояркина А. П., Одинцова И.Н., Гурина Л.И., Алексеева Г.Н. Эпидемиология рака почки в регионе Сибири и Дальнего Востока (1994-2008) // Урология, 2013. No 3. С. 52-56. [Pisareva L.F., Bojarkina A.P., Odincova I.N., Gurina L.I., Alekseeva G.N. The epidemiology of kidney cancer in the region of Siberia and the Far East (1994-2008). Urologiya = Urology, 2013, no. 3, pp. 52-56. (In Russ.)]
7. Савченко А.А., Здзитовецкий А.Г., Борисов А.Г., Лузан Н.А. Хемилюминесцентная и энзиматическая активность нейтрофильных гранулоцитов у больных распространенным гнойным перитонитом в зависимости от исхода заболевания // Вестник РАМН, 2014. No 4-5. С. 23-28. [Savchenko A.A., Zdzitovetskiy D.E., Borisov A.G., Luzan N.A. Chemiluminescent and Enzyme Activity of Neutrophils in Patients with Widespread Purulent Peritonitis Depending on the Outcome of Disease. Vestnik RAMN = Bulletin of the Russian Academy of Medical Sciences, 2014, no. 4-5, pp. 23-28. (In Russ.)]
8. Теблоева Л.М., Гусева О.А., Филиппов С.В., Хайдуков С.В. Активация и дифференцировка моноцитов периферической крови при пародонтите // Медицинская иммунология, 2014. Т. 16, No 2. С. 165-172. [Tebloeva L.M., Guseva O.A., Filippov S.V., Khajdukov S.V. Activation and differentiation of peripheral blood monocytes in periodontitis. Meditsinskaya immunologiya = Medical Immunology (Russia), 2014, Vol. 16, no. 2, pp. 165-172. (In Russ.)]
9. Хайдуков С.В., Байдун Л.А., Зурочка А.В., Тотолян Арег А. Стандартизованная технология «Исследование субпопуляционного состава лимфоцитов периферической крови с применением проточных цитофлюориметров-анализаторов» (Проект) // Медицинская иммунология, 2012. Т. 14, No 3. С. 255-268. [Khajdukov S.V., Bajdun L.A., Zurochka A.V., Totolian Areg A. Standardized technology «Research of lymphocytes subpopulation composition in peripheral blood using flow cytometry analyzers» (Draft). Meditsinskaya immunologiya = Medical Immunology (Russia), 2012, Vol. 14, no. 3, pp. 255-268. (In Russ.)]
10. Ярилин А.А. Иммунология. М.: ГЭОТАР-Медиа, 2010. 752 с. [Yarilin A.A. Immunology]. Moscow: GAOTAR-Media, 2010. 752 p.
11. Abern M.R., Scosyrev E., Tsivian M., Messing E.M., Polascik T.J., Dudek A.Z. Survival of patients undergoing cytoreductive surgery for metastatic renal cell carcinoma in the targeted-therapy era. Anticancer Res., 2014, Vol. 34, no. 5, pp. 2405-2411.
12. Appleby L.J., Nausch N., Midzi N., Mduluza T., Allen J.E., Mutapi F. Sources of heterogeneity in human monocyte subsets. Immunol. Lett., 2013, Vol. 152, no. 1, pp. 32-41.
13. Becze E. Stress and inflammation combine to fuel cancer growth. ONS Connect., 2014, Vol. 29, no. 4, pp. 30-31.
14. Demaret J., Walencik A., Jacob M.C., Timsit J.F., Venet F., Lepape A., Monneret G. Inter-laboratory assessment of flow cytometric monocyte HLA-DR expression in clinical samples. Cytometry B Clin. Cytom., 2013, Vol. 84, no. 1, pp. 59-62.
15. Farkas A., Kemény L. Monocyte-derived interferon-alpha primed dendritic cells in the pathogenesis of psoriasis: new pieces in the puzzle. Int. Immunopharmacol., 2012, Vol. 13, no. 2. pp. 215-218.
16. Gao Y., Huang D. The value of the systematic inflammation-based Glasgow Prognostic Score in patients with gastric cancer: A literature review. J. Cancer Res. Ther., 2014, Vol. 10, no. 4, pp. 799-804.
17. Gordon S. Targeting a monocyte subset to reduce inflammation. Circ. Res., 2012, Vol. 110, no. 12, pp. 15461548.
18. Hristov M., Schmitz S., Nauwelaers F., Weber C. A flow cytometric protocol for enumeration of endothelial progenitor cells and monocyte subsets in human blood. J. Immunol. Methods, 2012, Vol. 381, no. 1-2, pp. 9-13.
19. Ishizuka M., Oyama Y., Abe A., Tago K., Tanaka G., Kubota K. Clinical Significance of an Inflammationbased Prognostic System for Gastric Cancer Patients with a Preoperative Normal Serum Level of Carcinoembryonic Antigen. Anticancer Res., 2014, Vol. 34, no. 12, pp. 7219-7226.
20. Langlet C., Tamoutounour S., Henri S., Luche H., Ardouin L., Grégoire C., Malissen B., Guilliams M. CD64 expression distinguishes monocyte-derived and conventional dendritic cells and reveals their distinct role during intramuscular immunization. J. Immunol., 2012, Vol. 188, no. 4, pp. 1751-1760.
21. Lauvau G., Chorro L., Spaulding E., Soudja S.M. Inflammatory monocyte effector mechanisms. Cell Immunol., 2014, Vol. 291, no. 1-2, pp. 32-40.
22. Li Y., Lee P.Y., Kellner E.S., Paulus M., Switanek J., Xu Y., Zhuang H., Sobel E.S., Segal M.S., Satoh M., Reeves W.H. Monocyte surface expression of Fcgamma receptor RI (CD64), a biomarker reflecting type-I interferon levels in systemic lupus erythematosus. Arthritis Res. Ther., 2010, Vol. 12, no. 3, p. 90.
23. Luider J.1., Cyfra M., Johnson P., Auer I. Impact of the new Beckman Coulter Cytomics FC 500 5-color flow cytometer on a regional flow cytometry clinical laboratory service. Lab. Hematol., 2004, Vol. 10, pp. 102-108.
24. Maecker H., McCoy P., Nussenblatt R. Standardizing immunophenotyping for the human immunology project. Nat. Rev. Immunol., 2012, Vol. 12, pp. 191-200.
25. Mancardi D.A., Albanesi M., Jönsson F., Iannascoli B., van Rooijen N., Kang X., England P., Daëron M., Bruhns P. The high-affinity human IgG receptor FcγRI (CD64) promotes IgG-mediated inflammation, anaphylaxis, and antitumor immunotherapy. Blood, 2013, Vol. 121, no. 9, pp. 1563-1573.
26. Monneret G., Venet F. Monocyte HLA-DR in sepsis: shall we stop following the flow? Crit. Care, 2014, Vol. 18, no. 1, pp. 102.
27. Nocca G., De Sole P., Gambarini G., De Palma F., Parziale V., Giardina B., Lupi A. Alteration of monocytic cell oxidative burst caused by methacrylic monomers present in dental materials: a chemiluminescence study. Luminescence, 2006, Vol. 21, no. 3, pp. 202-206.
28. Qu C., Brinck-Jensen N.S., Zang M., Chen K. Monocyte-derived dendritic cells: targets as potent antigenpresenting cells for the design of vaccines against infectious diseases. Int. J. Infect. Dis., 2014, Vol. 19, pp. 1-5.
29. Serbina N.V., Shi C., Pamer E.G. Monocyte-mediated immune defense against murine Listeria monocytogenes infection. Adv. Immunol., 2012, Vol. 113, pp. 119-134.
30. Shi C., Pamer E.G. Monocyte recruitment during infection and inflammation. Nat. Rev. Immunol., 2011, Vol. 11, no. 11, pp. 762-774.
31. Skrzeczyńska-Moncznik J., Bzowska M., Loseke S., Grage-Griebenow E., Zembala M., Pryjma J. Peripheral blood CD14high CD16+ monocytes are main producers of IL-10. Scandinavian Journal of Immunology, 2008, Vol. 67, no. 2, pp. 152-159.
32. Stec M., Baran J., Baj-Krzyworzeka M., Weglarczyk K., Gozdzik J., Siedlar M., Zembala M. Chemokine receptors and chemokine production by CD34+ stem cell-derived monocytes in response to cancer cells. Anticancer Res., 2012, Vol. 32, no. 11, pp. 4749-4753.
33. Strehl C., Fangradt M., Fearon U., Gaber T., Buttgereit F., Veale D.J. Hypoxia: how does the monocytemacrophage system respond to changes in oxygen availability? J. Leukoc. Biol., 2014, Vol. 95, no. 2, pp. 233-241.
34. Tallone T., Turconi G., Soldati G., Pedrazzini G., Moccetti T., Vassalli G. Heterogeneity of human monocytes: an optimized four-color flow cytometry protocol for analysis of monocyte subsets. J. Cardiovasc. Transl. Res., 2011, Vol. 4, no. 2, pp. 211-219.
35. Tolouei Semnani R., Moore V., Bennuru S., McDonald-Fleming R., Ganesan S., Cotton R., Anuradha R., Babu S., Nutman T.B. Human monocyte subsets at homeostasis and their perturbation in numbers and function in filarial infection. Infect. Immun., 2014, Vol. 82, no. 11, pp. 4438-4446.
36. Zhan Y., Wu L. Functional regulation of monocyte-derived dendritic cells by microRNAs. Protein Cell, 2012, Vol. 3, no. 7, pp. 497-507.
37. Ziegler-Heitbrock L. Monocyte subsets in man and other species. Cell Immunol., 2014, Vol. 289, no. 1-2, pp. 135-139.
38. Ziegler-Heitbrock L., Ancuta P., Crowe S., Dalod M., Grau V., Hart D.N., Leenen P.J., Liu Y.J., MacPherson G., Randolph G.J., Scherberich J., Schmitz J., Shortman K., Sozzani S., Strobl H., Zembala M., Austyn J.M., Lutz M.B. Nomenclature of monocytes and dendritic cells in blood. Blood, 2010, Vol. 116, no. 16, pp. 74-80.
Review
For citations:
Savchenko A.A., Borisov A.G., Modestov A.A., Moshev A.V., Kudryavtsev I.V., Tonacheva O.G., Koshcheev V.N. MONOCYTES SUBPOPULATIONS AND CHEMILUMINESCENT ACTIVITY IN PATIENTS WITH RENAL CELL CARCINOMA. Medical Immunology (Russia). 2015;17(2):141-150. (In Russ.) https://doi.org/10.15789/1563-0625-2015-2-141-150
Views:
1094
Email this article 